{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:38:10Z","timestamp":1792633090826,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:00:00Z","timestamp":1792627200000},"content-version":"vor","delay-in-days":90,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["RfPB202212"],"award-info":[{"award-number":["RfPB202212"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Urinary and faecal incontinence affects millions. Community pharmacies provide local community healthcare highlighting opportunity for innovation in continence promotion. The Pharmacy Role In the proMotion of continencE (PRIME) study was conducted to investigate development of a Pharmacy Bladder and Bowel Service (PBBS) incorporating key stakeholder engagement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A UK online survey, employing convenience sampling of community pharmacy staff identified current practice, and barriers and facilitators to PBBS development, between July and November 2022. These findings were incorporated into an evidence brief supported by findings from earlier PRIME sub-studies (systematic literature review and qualitative interviews). The evidence brief guided stakeholder participant workshop discussions using co-production methodology, during April and June 2023, to derive a protocolised service specification for the PBBS, detailing underpinning requirements and scope of service, as the final stage of this study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twenty-nine community pharmacy participants completed the survey reporting some provision of lifestyle advice in practice with clear scope for expansion. Subsequently, sixteen participants including Community Pharmacists, Bladder and Bowel Service staff, Service users and healthcare commissioners participated in two workshops. The PPBS service specification outlined three tiers of service provision: tier 1 \u2013 awareness raising, education and signposting; tier 2 \u2013 assessment and self-help advice; tier 3 \u2013 specialist input involving specific treatment strategies. Acknowledged limitations are the pressures and relatively novel nature of pharmacy research which presents challenge in promoting participation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This is the first evidence-based PBBS service specification, developed to inform future practice. Key requirements include record sharing, advances in training, and reimbursement to enable the PBBS to be viable for community pharmacy provision. The PBBS provides potential for early identification, promotion of continence health, and self-help activation in community settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12913-026-15123-8","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T12:33:20Z","timestamp":1784896400000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pharmacy role in the proMotion of continencE (PRIME): a co-production study to develop a pharmacy bladder and bowel service"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6921-2712","authenticated-orcid":false,"given":"Nikki","family":"Cotterill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Uren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ade","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Chandler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoba","family":"Dawson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,24]]},"reference":[{"key":"15123_CR1","unstructured":"NHS England. Excellence in continence care: practical guidance for commissioners, and leaders in health and social care. 2018."},{"key":"15123_CR2","unstructured":"Cardozo L, Rovner E, Wagg A, Wein A, editors. Incontinence: Proceedings of the seventh international consultation on incontinence. Plymouth: Health Publications Ltd; 2023."},{"key":"15123_CR3","unstructured":"Bladder and Bowel CONfidence Health Integration Team, West of England Academic Health Science Network, Disruptive Thinking. Create Open Health: Voices for Change [Internet]. Bristol. 2022 [cited 2022 Nov 9]. Available from: https:\/\/www.weahsn.net\/our-work\/supporting-innovation\/create-open-health-voices-for-change\/."},{"key":"15123_CR4","unstructured":"Bladder and Bowel CONfidence Health Integration Team, Healthwatch BNSSH. User Experiences of Bladder & Bowel Services during the Pandemic [Internet]. Bristol; 2022 [cited 2022 Nov 9]. Available from: https:\/\/www.healthwatchbristol.co.uk\/report\/2022-04-06\/report-how-has-covid-19-pandemic-affected-peoples-experiences-bladder-and-bowel."},{"key":"15123_CR5","doi-asserted-by":"publisher","unstructured":"Cotterill N, Schroeder K. CONfidence: developing an app to promote bladder and bowel health. 2024 Apr 16. https:\/\/doi.org\/10.1177\/09544119241246848.","DOI":"10.1177\/09544119241246848"},{"key":"15123_CR6","unstructured":"National Institute for Health and Care Excellence. Urinary incontinence and pelvic organ prolapse in women: management. NG123. NICE Guideline [Internet]. 2019 [cited 2022 Nov 9]. Available from: https:\/\/www.nice.org.uk\/guidance\/ng123\/resources\/urinary-incontinence-and-pelvic-organ-prolapse-in-women-management-pdf-66141657205189."},{"key":"15123_CR7","unstructured":"National Institute for Clinical Excellence. Faecal incontinence in adults: management Clinical Guideline. (CG49). 2007."},{"key":"15123_CR8","doi-asserted-by":"publisher","unstructured":"Todd A, Copeland A, Husband A, Kasim A, Bambra C. The positive pharmacy care law: an area-level analysis of the relationship between community pharmacy distribution, urbanity and social deprivation in England. BMJ Open. 2014;4(8). https:\/\/doi.org\/10.1136\/bmjopen-2014-005764.","DOI":"10.1136\/bmjopen-2014-005764"},{"key":"15123_CR9","unstructured":"NHS England. 2024\/25 priorities and operational planning guidance. 2024."},{"issue":"4","key":"15123_CR10","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1177\/1715163519852378","volume":"152","author":"E Duong","year":"2019","unstructured":"Duong E, Al Hamarneh YN, Tsuyuki RT, Wagg A, Hunter KF, Schulz J, et al. Case finding for urinary incontinence and falls in older adults at community pharmacies. Can Pharmacists J. 2019;152(4):228\u201333. https:\/\/doi.org\/10.1177\/1715163519852378.","journal-title":"Can Pharmacists J"},{"key":"15123_CR11","unstructured":"NHS England. The community pharmacy contractual framework for 2019\/20-2023\/24: supporting delivery for the NHS long term plan. 2019:1\u20136."},{"key":"15123_CR12","unstructured":"NHS England. Community pharmacy advanced service specification: NHS Pharmacy First Service. 2023."},{"key":"15123_CR13","doi-asserted-by":"crossref","unstructured":"Gordon DS, Howat P. Community pharmacies: an ideal setting to promote continence. Aust N Z Continence J. 2005;11(3):60. Available from: http:\/\/search.ebscohost.com\/login.aspx?direct=true&AuthType=ip,shib&db=c8h&AN=2009108695&site=ehost-live&custid=s4121186","DOI":"10.1071\/CJ05025"},{"issue":"8","key":"15123_CR14","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.sapharm.2024.04.010","volume":"20","author":"A Uren","year":"2024","unstructured":"Uren A, Dawson S, Cotterill N, Williams A, McLeod H, Chandler D, et al. The role of community pharmacy in the promotion of continence care: A systematic review. Res Social Administrative Pharm. 2024;20(8):689\u201396. https:\/\/doi.org\/10.1016\/j.sapharm.2024.04.010. PubMed PMID: 38772839.","journal-title":"Res Social Administrative Pharm"},{"issue":"10","key":"15123_CR15","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.sapharm.2024.07.003","volume":"20","author":"A Uren","year":"2024","unstructured":"Uren A, Watson M, Dawson S, Williams A, McLeod H, Chandler D, et al. Identifying the key determinants of a community pharmacy based bladder and bowel service. Res Social Administrative Pharm. 2024;20(10):1006\u201313. https:\/\/doi.org\/10.1016\/j.sapharm.2024.07.003 . PubMed PMID: 39097478.","journal-title":"Res Social Administrative Pharm"},{"key":"15123_CR16","doi-asserted-by":"publisher","unstructured":"Skivington K, Matthews L, Simpson SA, Craig P, Baird J, Blazeby JM, et al. A new framework for developing and evaluating complex interventions: update of medical research council guidance. BMJ. 2021 Sep 30. https:\/\/doi.org\/10.1136\/bmj.n2061.","DOI":"10.1136\/bmj.n2061"},{"key":"15123_CR17","unstructured":"Brant JM, Haas-Haseman ML, Wei SH, Wickham R, Ponto J. Understanding and evaluating survey research. 2015."},{"key":"15123_CR18","unstructured":"Nesta. People powered health co-production catalogue [Internet]. 2013 [cited 2026 Jun 12]. Available from: https:\/\/media.nesta.org.uk\/documents\/co-production_catalogue.pdf."},{"issue":"5","key":"15123_CR19","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1136\/qshc.2005.016527","volume":"15","author":"P Bate","year":"2006","unstructured":"Bate P, Robert G. Experience-based design: from redesigning the system around the patient to co-designing services with the patient. BMJ Qual Saf. 2006;15(5):307\u201310. 10.1136\/. QSHC.2005.016527 PubMed PMID: 17074863.","journal-title":"BMJ Qual Saf"},{"key":"15123_CR20","unstructured":"Realpe A, Wallace LM. What is co-production? Health Foundation. 2010;19."},{"issue":"31","key":"15123_CR21","first-page":"357","volume":"12","author":"AJ Culyer","year":"2006","unstructured":"Culyer AJ, Lomas J. Deliberative Process and Evidence-Informed Decision-Making in Health Care: Do They Work and How Might We Know? 12. 2006;12(31):357\u201371.","journal-title":"12"},{"key":"15123_CR22","unstructured":"Clegg D, Barker R. Case method fast-track: a RAD approach. Addison-Wesley Longman Publishing Co. Inc; 1994."},{"key":"15123_CR23","doi-asserted-by":"publisher","first-page":"e006682","DOI":"10.1136\/bmjopen-2014-006682","volume":"4","author":"S Slade","year":"2014","unstructured":"Slade S, Dionne C, Underwood M. Standardised method for reporting exercise programmes: protocol for a modified Delphi study. BMJ Open. 2014;4:e006682\u2013undefined.","journal-title":"BMJ Open"},{"key":"15123_CR24","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.jclinepi.2013.12.002","volume":"67","author":"I Diamond","year":"2014","unstructured":"Diamond I, Grant R, Feldman B. Defining consensus: a systematic review recommends methodologic criteria for reporting of Delphi studies. J Clin Epidemiol. 2014;67:401\u20139.","journal-title":"J Clin Epidemiol"},{"key":"15123_CR25","doi-asserted-by":"crossref","unstructured":"Skivington K, Matthews L, Simpson SA, Craig P, Baird J, Blazeby JM, et al. A new framework for developing and evaluating complex interventions: Update of medical research council guidance. BMJ. 2021;374. https:\/\/doi.org\/10.1136.\/bmj.n2061. PubMed PMID: 34593508.","DOI":"10.1136\/bmj.n2061"},{"key":"15123_CR26","unstructured":"House of Commons Health and Social Care Committee Expert Panel. Evaluation of the Government's commitments in the area of pharmacy in England: Tenth Special Report of Session 2022\u201323 [Internet]. 2023. Available from: https:\/\/www.parliament.uk\/hsccom."},{"key":"15123_CR27","doi-asserted-by":"crossref","unstructured":"Taylor DW, Cahill JJ. From stigma to the spotlight: a need for patient-centred incontinence care. Healthc Manage Forum. 2018. Epub ahead.","DOI":"10.1177\/0840470418798102"},{"key":"15123_CR28","unstructured":"General Pharmaceutical Council. The GPhC register as of 31 March 2024 - Trend data. 2024."}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-026-15123-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-15123-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-026-15123-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T00:38:05Z","timestamp":1792629485000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-026-15123-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["15123"],"URL":"https:\/\/doi.org\/10.1186\/s12913-026-15123-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5333540\/v1","asserted-by":"object"}]},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"25 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"NHS Health Research Authority approval was secured (22\/HRA\/2388 and 23\/HRA\/0586) and University ethics approval was granted by the University of the West of England (HAS.22.06.117 and HAS.23.02.074), for the survey and co-production sub-studies respectively. Informed consent was provided by all participants and the study was conducted in accordance with the Declaration of Helsinki.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1445"}}